dalteparin has been researched along with Adrenocorticotropic Hormone, Inappropriate Secretion in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbot, M | 1 |
| Daidone, V | 1 |
| Zilio, M | 1 |
| Albiger, N | 1 |
| Mazzai, L | 1 |
| Sartori, MT | 1 |
| Frigo, AC | 1 |
| Scanarini, M | 1 |
| Denaro, L | 1 |
| Boscaro, M | 1 |
| Casonato, S | 1 |
| Ceccato, F | 1 |
| Scaroni, C | 1 |
1 other study available for dalteparin and Adrenocorticotropic Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Aged; Anticoagulants; Antithrombin III; Case-Contr | 2015 |